Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
[7] Pre-clinical research has indicated that BPC-157 may have cytoprotective, neuroprotective, and anti-inflammatory effects, and may also accelerate tissue and organ healing
Oral doses tend to be higher - 500 mcg to 1000 mcg twice daily - because oral bioavailability is presumably lower than injectable, though we don't have good human pharmacokinetic data
Practical Application: Works best when integrated into a structured cycle (46 weeks on, 24 weeks off)
Personal vials reduce cross-contamination and preserve the integrity of products
On a weekly basis, the research subject is receiving roughly 3.5mg of BPC-157 and 17.5mg of TB-500
FAQ Dosing basics What is the starting dose of tirzepatide
US$ 22.25
US$ 23.80
US$ 25.75
